Several studies have also shown that the recruitment of CCR1+ myeloid cells via CCR1 ligands, such as CCL2, CCL9 and CCL15, promotes invasion, metastasis, and angiogenesis in CRC and other tumor types [8, 13, 34–37]. This evidence concerns the gene CCR1 and neoplasm.